logo

Acasti Pharma, Inc. (ACST)



Trade ACST now with
  Date
  Headline
1/13/2020 6:13:53 AM Axsome Therapeutics Enters License Agreement With Pfizer For Reboxetine
1/13/2020 6:11:14 AM Acasti Pharma: TRILOGY 1 Phase 3 Trial Of CaPre Did Not Reach Statistical Significance
1/13/2020 6:10:50 AM Acasti Pharma Says TRILOGY 1 Phase 3 Trial Of CaPre Did Not Reach Statistical Significance
5/10/2019 7:35:16 AM Acasti Pharma Settles Claims Made By Its Former CEO
12/31/2018 8:01:54 AM Acasti Pharma Announces TRILOGY Phase 3 Trials Of CaPre
12/20/2018 8:14:24 AM Acasti Pharma Reaches Enrollment Targets For TRILOGY Phase 3 Trials Of CaPre In Patients With Severe HTG
11/14/2018 8:16:36 AM Acasti Pharma Q2 Net Loss C$22.7 Mln Or C$0.62 Per Share
10/3/2018 4:30:57 PM Acasti Pharma Announces Proposed Public Offering Of Common Shares
  
 
>